(Q39805940)

14 September 2017

1 reference

title

Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer (English)

1 reference

14 September 2017

Rationale and experimental design for the va cooperative study of anticoagulation (warfarin) in the treatment of cancer (English)

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

circulating tumor cell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

author name string

Cornell CJ Jr

5

1 reference

14 September 2017

L. R. Zacharski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

W. G. Henderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

F. R. Rickles

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

W. B. Forman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

C. J. Cornell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

R. J. Forcier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

H. W. Harrower

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

R. O. Johnson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383261

15 April 2023

language of work or name

English

0 references

publication date

1 August 1979

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

1 reference

14 September 2017

volume

44

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

732-741

1 reference

Cor pulmonale due to tumor emboli; review of literature and report of a case

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197908%2944%3A2%3C732%3A%3AAID-CNCR2820440246%3E3.0.CO%3B2-Y

Anticoagulants in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197908%2944%3A2%3C732%3A%3AAID-CNCR2820440246%3E3.0.CO%3B2-Y

The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197908%2944%3A2%3C732%3A%3AAID-CNCR2820440246%3E3.0.CO%3B2-Y

The Effects of Acetylsalicylic Acid and Dipyridamole on Platelet Economy in Metastatic Cancer

21 January 2018

1

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Enhancement of Pulmonary Metastases following the Intravenous Infusion of a Suspension of Ellagic Acid

15 April 2023

2

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Decrease in pulmonary metastases: potentiation of nitrogen mustard effect by heparin and fibrinolysin

15 April 2023

3

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

7

20

1488

Bale

1960

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

11

33

1217

Brown

1973

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells

15 April 2023

12

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Serine enzymes released by cultured neoplastic cells

15 April 2023

14

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Prophylactic heparin therapy in acute promyelocytic leukemia

15 April 2023

18

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

Cancer Treatment Reports

21

60

575

Edlis

1976

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Increasing the efficiency of cancer chemotherapy with heparin: "clinical study".

15 April 2023

22

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Heparin and chemotherapy in the management of inoperable lung carcinoma

15 April 2023

23

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Anti-metastatic effect of aspirin

15 April 2023

24

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Cancer procoagulant A: A factor X activating procoagulant from malignant tissue

15 April 2023

26

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor

15 April 2023

27

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

15 April 2023

28

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Platelet and fibrinogen consumption in man.

15 April 2023

29

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

31

20

592

Hiramoto

1960

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Techniques for inhibiting tumor metastases

15 April 2023

33

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Osteosarcoma.Improved Survival with Anticoagulation and Amputation

15 April 2023

34

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Clotting factors and metastasis formation

15 April 2023

38

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Prophylaxis of metastases formation by unspecific immunologic stimulation associated with heparintherapy

15 April 2023

39

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Stimulation of human leukocyte thromboplastic activity by endotoxin.

15 April 2023

42

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Localization of intracranial tumors.Comparative study with131I-labeled antibody to human fibrinogen and neohydrin-203Hg

15 April 2023

43

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY

15 April 2023

46

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

54

49

627

1974

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Experimental studies on the mechanisms of fibrinogen uptake in a rat tumour

15 April 2023

56

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Tumors, mucus production, and hypercoagulability

15 April 2023

58

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells

15 April 2023

60

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

Cancer Treatment Reports

62

61

1399

Rohwedder

1977

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Warfarin Treatment of Mice Bearing Autochthonous Tumors: Effect on Spontaneous Metastases

15 April 2023

63

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia

15 April 2023

65

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome

15 April 2023

66

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

INTERFERENCE IN LOCALIZATION OF I-131 FIBRINOGEN IN RAT TUMORS BY ANTICOAGULANTS

15 April 2023

68

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Electron microscopic observations on formation of pulmonary metastases

15 April 2023

70

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

71

20

1501

Spar

1960

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

131I-labeled antibodies to human fibrinogen.Diagnostic studies and therapeutic trials

15 April 2023

72

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

78

32

280

Thornes

1972

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

B.C.G. plus protease L in malignant melanoma

15 April 2023

79

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants

15 April 2023

81

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

Fibrin and cancer

83

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Loss of hepatoma ribosomal RNA during warfarin therapy

15 April 2023

84

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

Incidence and clinical significance of tumor embolization to the lungs

15 April 2023

91

1 reference

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197908)44:2%3C732::AID-CNCR2820440246%3E3.0.CO;2-Y

15 April 2023

Identifiers

10.1002/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y

1 reference

14 September 2017

1 reference